1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Sedation In ICU Setting Revenue 1.4 Market Analysis by Type 1.4.1 Global Sedation In ICU Setting Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Propofol 1.4.3 Dexmedetomidine 1.4.4 Remifentanil 1.4.5 Others 1.5 Market by Application 1.5.1 Global Sedation In ICU Setting Market Share by Application: 2020 VS 2026 1.5.2 Neonatal Intensive Care Unit 1.5.3 Child Intensive Care Unit 1.5.4 Adult Intensive Care Unit 1.6 Coronavirus Disease 2019 (Covid-19): Sedation In ICU Setting Industry Impact 1.6.1 How the Covid-19 is Affecting the Sedation In ICU Setting Industry 1.6.1.1 Sedation In ICU Setting Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Sedation In ICU Setting Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Sedation In ICU Setting Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Sedation In ICU Setting Market Perspective (2015-2026) 2.2 Sedation In ICU Setting Growth Trends by Regions 2.2.1 Sedation In ICU Setting Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Sedation In ICU Setting Historic Market Share by Regions (2015-2020) 2.2.3 Sedation In ICU Setting Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Sedation In ICU Setting Market Growth Strategy 2.3.6 Primary Interviews with Key Sedation In ICU Setting Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Sedation In ICU Setting Players by Market Size 3.1.1 Global Top Sedation In ICU Setting Players by Revenue (2015-2020) 3.1.2 Global Sedation In ICU Setting Revenue Market Share by Players (2015-2020) 3.1.3 Global Sedation In ICU Setting Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Sedation In ICU Setting Market Concentration Ratio 3.2.1 Global Sedation In ICU Setting Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Sedation In ICU Setting Revenue in 2019 3.3 Sedation In ICU Setting Key Players Head office and Area Served 3.4 Key Players Sedation In ICU Setting Product Solution and Service 3.5 Date of Enter into Sedation In ICU Setting Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Sedation In ICU Setting Historic Market Size by Type (2015-2020) 4.2 Global Sedation In ICU Setting Forecasted Market Size by Type (2021-2026) 5 Sedation In ICU Setting Breakdown Data by Application (2015-2026) 5.1 Global Sedation In ICU Setting Market Size by Application (2015-2020) 5.2 Global Sedation In ICU Setting Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Sedation In ICU Setting Market Size (2015-2020) 6.2 Sedation In ICU Setting Key Players in North America (2019-2020) 6.3 North America Sedation In ICU Setting Market Size by Type (2015-2020) 6.4 North America Sedation In ICU Setting Market Size by Application (2015-2020) 7 Europe 7.1 Europe Sedation In ICU Setting Market Size (2015-2020) 7.2 Sedation In ICU Setting Key Players in Europe (2019-2020) 7.3 Europe Sedation In ICU Setting Market Size by Type (2015-2020) 7.4 Europe Sedation In ICU Setting Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Sedation In ICU Setting Market Size (2015-2020) 8.2 Sedation In ICU Setting Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Sedation In ICU Setting Market Size by Type (2015-2020) 8.4 Asia-Pacific Sedation In ICU Setting Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 AstraZeneca 9.1.1 AstraZeneca Company Details 9.1.2 AstraZeneca Business Overview and Its Total Revenue 9.1.3 AstraZeneca Sedation In ICU Setting Introduction 9.1.4 AstraZeneca Revenue in Sedation In ICU Setting Business (2015-2020)) 9.1.5 AstraZeneca Recent Development 9.2 GlaxoSmithKline 9.2.1 GlaxoSmithKline Company Details 9.2.2 GlaxoSmithKline Business Overview and Its Total Revenue 9.2.3 GlaxoSmithKline Sedation In ICU Setting Introduction 9.2.4 GlaxoSmithKline Revenue in Sedation In ICU Setting Business (2015-2020) 9.2.5 GlaxoSmithKline Recent Development 9.3 Mylan 9.3.1 Mylan Company Details 9.3.2 Mylan Business Overview and Its Total Revenue 9.3.3 Mylan Sedation In ICU Setting Introduction 9.3.4 Mylan Revenue in Sedation In ICU Setting Business (2015-2020) 9.3.5 Mylan Recent Development 9.4 Fresenius 9.4.1 Fresenius Company Details 9.4.2 Fresenius Business Overview and Its Total Revenue 9.4.3 Fresenius Sedation In ICU Setting Introduction 9.4.4 Fresenius Revenue in Sedation In ICU Setting Business (2015-2020) 9.4.5 Fresenius Recent Development 9.5 Teva 9.5.1 Teva Company Details 9.5.2 Teva Business Overview and Its Total Revenue 9.5.3 Teva Sedation In ICU Setting Introduction 9.5.4 Teva Revenue in Sedation In ICU Setting Business (2015-2020) 9.5.5 Teva Recent Development 9.6 B. Braun Holding 9.6.1 B. Braun Holding Company Details 9.6.2 B. Braun Holding Business Overview and Its Total Revenue 9.6.3 B. Braun Holding Sedation In ICU Setting Introduction 9.6.4 B. Braun Holding Revenue in Sedation In ICU Setting Business (2015-2020) 9.6.5 B. Braun Holding Recent Development 9.7 Aspen 9.7.1 Aspen Company Details 9.7.2 Aspen Business Overview and Its Total Revenue 9.7.3 Aspen Sedation In ICU Setting Introduction 9.7.4 Aspen Revenue in Sedation In ICU Setting Business (2015-2020) 9.7.5 Aspen Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Sedation In ICU Setting Key Market Segments Table 2. Key Players Covered: Ranking by Sedation In ICU Setting Revenue Table 3. Ranking of Global Top Sedation In ICU Setting Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Sedation In ICU Setting Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Propofol Table 6. Key Players of Dexmedetomidine Table 7. Key Players of Remifentanil Table 8. Key Players of Others Table 9. COVID-19 Impact Global Market: (Four Sedation In ICU Setting Market Size Forecast Scenarios) Table 10. Opportunities and Trends for Sedation In ICU Setting Players in the COVID-19 Landscape Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 12. Key Regions/Countries Measures against Covid-19 Impact Table 13. Proposal for Sedation In ICU Setting Players to Combat Covid-19 Impact Table 14. Global Sedation In ICU Setting Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 15. Global Sedation In ICU Setting Market Size by Regions (US$ Million): 2020 VS 2026 Table 16. Global Sedation In ICU Setting Market Size by Regions (2015-2020) (US$ Million) Table 17. Global Sedation In ICU Setting Market Share by Regions (2015-2020) Table 18. Global Sedation In ICU Setting Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 19. Global Sedation In ICU Setting Market Share by Regions (2021-2026) Table 20. Market Top Trends Table 21. Key Drivers: Impact Analysis Table 22. Key Challenges Table 23. Sedation In ICU Setting Market Growth Strategy Table 24. Main Points Interviewed from Key Sedation In ICU Setting Players Table 25. Global Sedation In ICU Setting Revenue by Players (2015-2020) (Million US$) Table 26. Global Sedation In ICU Setting Market Share by Players (2015-2020) Table 27. Global Top Sedation In ICU Setting Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sedation In ICU Setting as of 2019) Table 28. Global Sedation In ICU Setting by Players Market Concentration Ratio (CR5 and HHI) Table 29. Key Players Headquarters and Area Served Table 30. Key Players Sedation In ICU Setting Product Solution and Service Table 31. Date of Enter into Sedation In ICU Setting Market Table 32. Mergers & Acquisitions, Expansion Plans Table 33. Global Sedation In ICU Setting Market Size by Type (2015-2020) (Million US$) Table 34. Global Sedation In ICU Setting Market Size Share by Type (2015-2020) Table 35. Global Sedation In ICU Setting Revenue Market Share by Type (2021-2026) Table 36. Global Sedation In ICU Setting Market Size Share by Application (2015-2020) Table 37. Global Sedation In ICU Setting Market Size by Application (2015-2020) (Million US$) Table 38. Global Sedation In ICU Setting Market Size Share by Application (2021-2026) Table 39. North America Key Players Sedation In ICU Setting Revenue (2019-2020) (Million US$) Table 40. North America Key Players Sedation In ICU Setting Market Share (2019-2020) Table 41. North America Sedation In ICU Setting Market Size by Type (2015-2020) (Million US$) Table 42. North America Sedation In ICU Setting Market Share by Type (2015-2020) Table 43. North America Sedation In ICU Setting Market Size by Application (2015-2020) (Million US$) Table 44. North America Sedation In ICU Setting Market Share by Application (2015-2020) Table 45. Europe Key Players Sedation In ICU Setting Revenue (2019-2020) (Million US$) Table 46. Europe Key Players Sedation In ICU Setting Market Share (2019-2020) Table 47. Europe Sedation In ICU Setting Market Size by Type (2015-2020) (Million US$) Table 48. Europe Sedation In ICU Setting Market Share by Type (2015-2020) Table 49. Europe Sedation In ICU Setting Market Size by Application (2015-2020) (Million US$) Table 50. Europe Sedation In ICU Setting Market Share by Application (2015-2020) Table 51. Asia-Pacific Key Players Sedation In ICU Setting Revenue (2019-2020) (Million US$) Table 52. Asia-Pacific Key Players Sedation In ICU Setting Market Share (2019-2020) Table 53. Asia-Pacific Sedation In ICU Setting Market Size by Type (2015-2020) (Million US$) Table 54. Asia-Pacific Sedation In ICU Setting Market Share by Type (2015-2020) Table 55. Asia-Pacific Sedation In ICU Setting Market Size by Application (2015-2020) (Million US$) Table 56. Asia-Pacific Sedation In ICU Setting Market Share by Application (2015-2020) Table 57. AstraZeneca Company Details Table 58. AstraZeneca Business Overview Table 59. AstraZeneca Product Table 60. AstraZeneca Revenue in Sedation In ICU Setting Business (2015-2020) (Million US$) Table 61. AstraZeneca Recent Development Table 62. GlaxoSmithKline Company Details Table 63. GlaxoSmithKline Business Overview Table 64. GlaxoSmithKline Product Table 65. GlaxoSmithKline Revenue in Sedation In ICU Setting Business (2015-2020) (Million US$) Table 66. GlaxoSmithKline Recent Development Table 67. Mylan Company Details Table 68. Mylan Business Overview Table 69. Mylan Product Table 70. Mylan Revenue in Sedation In ICU Setting Business (2015-2020) (Million US$) Table 71. Mylan Recent Development Table 72. Fresenius Company Details Table 73. Fresenius Business Overview Table 74. Fresenius Product Table 75. Fresenius Revenue in Sedation In ICU Setting Business (2015-2020) (Million US$) Table 76. Fresenius Recent Development Table 77. Teva Company Details Table 78. Teva Business Overview Table 79. Teva Product Table 80. Teva Revenue in Sedation In ICU Setting Business (2015-2020) (Million US$) Table 81. Teva Recent Development Table 82. B. Braun Holding Company Details Table 83. B. Braun Holding Business Overview Table 84. B. Braun Holding Product Table 85. B. Braun Holding Revenue in Sedation In ICU Setting Business (2015-2020) (Million US$) Table 86. B. Braun Holding Recent Development Table 87. Aspen Company Details Table 88. Aspen Business Overview Table 89. Aspen Product Table 90. Aspen Revenue in Sedation In ICU Setting Business (2015-2020) (Million US$) Table 91. Aspen Recent Development Table 92. Research Programs/Design for This Report Table 93. Key Data Information from Secondary Sources Table 94. Key Data Information from Primary Sources List of Figures Figure 1. Global Sedation In ICU Setting Market Share by Type: 2020 VS 2026 Figure 2. Propofol Features Figure 3. Dexmedetomidine Features Figure 4. Remifentanil Features Figure 5. Others Features Figure 6. Global Sedation In ICU Setting Market Share by Application: 2020 VS 2026 Figure 7. Neonatal Intensive Care Unit Case Studies Figure 8. Child Intensive Care Unit Case Studies Figure 9. Adult Intensive Care Unit Case Studies Figure 10. Sedation In ICU Setting Report Years Considered Figure 11. Global Sedation In ICU Setting Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Sedation In ICU Setting Market Share by Regions: 2020 VS 2026 Figure 13. Global Sedation In ICU Setting Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Sedation In ICU Setting Market Share by Players in 2019 Figure 16. Global Top Sedation In ICU Setting Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sedation In ICU Setting as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Sedation In ICU Setting Revenue in 2019 Figure 18. North America Sedation In ICU Setting Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Sedation In ICU Setting Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Asia-Pacific Sedation In ICU Setting Market Size YoY Growth (2015-2020) (Million US$) Figure 21. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 22. AstraZeneca Revenue Growth Rate in Sedation In ICU Setting Business (2015-2020) Figure 23. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. GlaxoSmithKline Revenue Growth Rate in Sedation In ICU Setting Business (2015-2020) Figure 25. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Mylan Revenue Growth Rate in Sedation In ICU Setting Business (2015-2020) Figure 27. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Fresenius Revenue Growth Rate in Sedation In ICU Setting Business (2015-2020) Figure 29. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Teva Revenue Growth Rate in Sedation In ICU Setting Business (2015-2020) Figure 31. B. Braun Holding Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. B. Braun Holding Revenue Growth Rate in Sedation In ICU Setting Business (2015-2020) Figure 33. Aspen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Aspen Revenue Growth Rate in Sedation In ICU Setting Business (2015-2020) Figure 35. Bottom-up and Top-down Approaches for This Report Figure 36. Data Triangulation Figure 37. Key Executives Interviewed

AstraZeneca GlaxoSmithKline Mylan Fresenius Teva B. Braun Holding Aspen